Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In the 1950s, multiple researchers , identified a new agent as the cause of acute respiratory disease (ARD), pharyngitis, conjunctivitis, and pneumonitis. Soon afterward, these agents were recognized to be a related group of viruses and given their present name: human adenoviruses (HAdVs).
The HAdVs have often been noted to cause respiratory illness among U.S. military trainees , and children. In the 1960s, HAdVs were found to infect as many as 80% of trainees, with 20% requiring hospitalization. Up to 40% of the trainees in a unit were lost to illness within a 2-week period, and many who were hospitalized had to restart training. HAdVs were also recognized to cause as much as 15% of instances of gastroenteritis in infants and children, and up to 10% of instances of pneumonia among hospitalized children. , HAdV morbidity can be severe and lead to death, especially in young children, transplantation recipients, and other immunocompromised patients.
The search for HAdV vaccines was driven by their morbidity among military trainees, their disruption to military training, and their medical care costs. In 1971, after a series of misstarts, military recruits began routinely receiving live oral enteric-coated vaccines for HAdV types 4 and 7 (HAd-4 and -7), which were safe and effective. Despite their morbidity being markedly controlled, in 1996, the sole vaccine manufacturer ceased production. As vaccine stores were depleted, U.S. military trainees again experienced large outbreaks of HAdV disease, with some deaths documented. In one comprehensive 2006 study, Russell and colleagues documented 98% HAdV-4 attack rates among 180 susceptible military recruits during 4 weeks of training. In 2011, HAdV-4 and -7 vaccine production was restarted, and the prevalence and morbidity of these viruses among military personnel was markedly reduced. The importance of these pathogens has been further emphasized through the recent emergence and morbidity of multiple novel HAdV-3, -4, -7, -14, and -55 strains as well as the recognition that animal adenoviruses have potential to cross species to man.
Within the genus Mastadenovirus , HAdVs are grouped into seven species (A through G) containing numerous unique types. Defining type uniqueness has been a matter of some professional debate with some virologists recognizing 51 unique serotypes through complex classical immunotyping techniques and others recognizing more than 110 unique genotypes through partial or full genome sequencing ( http://hadvwg.gmu.edu/ ). Adenoviruses may be described through their host, their species, their numeric type, and sometimes their subtype (stratified by restriction enzyme digests or phylogenetic data). HAdVs affect most organ systems and individual HAdV types often have preferred tissue tropisms that lead to specific syndromes ( Table 11.1 ).
Clinical Syndrome | Common Types | Population at Risk |
Respiratory, endemic | 1, 2, 3, 5, 6 | Infants, children |
Respiratory, epidemic | 3, 4, 7, 14, 55 | Children, adults |
Acute respiratory disease | 4, 7, 14, 21 | Military recruits |
Pharyngoconjunctival fever | 1, 2, 3, 4, 5, 7, 14 | School-age children, young adults |
Epidemic keratoconjunctivitis | 8, 19, 37, 53, 54 | All age groups |
Hemorrhagic cystitis | 11, 34, 35 | Immunocompromised patients, children |
Gastroenteritis | 31, 40, 41, 52 | Children, immunocompromised patients |
Other syndromes | 2, 4, 7, 12,19, 32, 37 | Children, adults |
Immune deficiency | 1, 2, 5, 11, 34, 35, 43–49, 50, 51 | Transplantation recipients, persons with AIDS, and immunocompromised patients |
Although most children become infected with many of the common HAdVs early in life, only about half of these infections result in disease. , , When patients are symptomatic, signs and symptoms often include fever, pharyngitis, bronchitis, conjunctivitis, bronchiolitis, cough, and pneumonia. The incubation period is often from 1 to 14 days. The incidence of HAdV disease is higher from late winter through early summer, and both sexes are equally affected. ,
A 2017 report indicated that HAdV-1, -2, -3, -4, -7, and -14 are most prevalent types recently reported in the United States. Occasionally, epidemics occur in daycare facilities, neonatal intensive care units, chronic care facilities, and orphanages, especially with HAdV-3, -4, and -7. , In addition to causing outbreaks in closed populations, HAdV-7 can cause large epidemics affecting children and adults in open communities. , , Other manifestations of HAdV infection include epidemic keratoconjunctivitis (often HAdV-8, -19, -37, -53, and -54), hemorrhagic cystitis syndrome (often HAdV-11 and -21), and diarrhea (often HAdV-40, and -41).
A number of case or outbreak reports primarily in young children document other, more unusual manifestations of HAdV infection. Although the studies are inconsistent, HAdV is implicated as a possible fetal pathogen. , HAdV infections among children are associated with sudden infant death, encephalitis, meningoencephalitis, cerebral edema, acute flaccid paralysis, pertussis-like syndromes, , mononucleosis-like syndromes, and neonatal disseminated infections. Among adults, HAdV infections have been associated with a toxic shock–like syndrome, encephalitis, genital lesions, orchitis, urethritis, and cervicitis. Nosocomial transmission to susceptible health care workers and patients has been reported. This is likely related to the long periods of viral shedding among HAdV-infected immunocompromised hosts, the possible aerosolization of the virus, and fomite transmission in the hospital setting. , ,
In unvaccinated young adults who live in military recruit camps, HAdVs may cause epidemics of febrile respiratory illness similar to influenza, including tracheobronchitis and pneumonia severe enough to require hospitalization , , , and occasionally death. The incubation period of the disease is often 4–5 days. Before the use of vaccines in the U.S. military, HAdV-4 and -7 accounted for 90% of all respiratory illnesses among recruits who were hospitalized, whereas HAdV-3, -14, and -21 were uncommon. At some northern basic training sites, rates of 6–8 per 100 trainees per week translated into 600–800 ARD hospital admissions per week. Recently, the newly recognized HAdV-55 (HAdV-11/14 recombinant) has been documented to have caused significant ARD morbidity among military trainees in multiple other countries.
Typical ARD is a febrile disease with symptoms of sore throat, fever, cough, coryza, rhinorrhea, headache, and chest pain. , , With extension into the lungs, physical examinations can reveal rales and rhonchi with little evidence of consolidation, and chest radiography often shows patchy interstitial infiltrates, principally in the lower lung fields. , , Symptoms last 3–10 days. Routes of transmission are thought to include direct contact or aerosolized virus inhalation. The virus has been isolated from the oropharynx more than 2 weeks after exposure. ,
HAdVs have been implicated as opportunistic agents in patients with immune deficiency, such as patients with AIDS, patients receiving cancer chemotherapy, and patients undergoing bone marrow solid organ transplantation. These patients are prone to pneumonia and disseminated adenoviral infection. They have also developed parotitis and urinary tract disease. A number of species D viruses, such as HAdV-43 through -49, have been recovered from people with AIDS. , A review of 201 bone marrow recipients over a 4-year period identified HAdV infections in 20.9%, with a higher incidence in children than in adults (31.3% vs 13.6%). HAdV-35 was the most common type identified. Hierholzer reported case fatality rates as high as 60% in HAdV-infected immunocompromised patients with pneumonia as compared with only 15% among immunocompetent pneumonia patients. A case fatality rate of 50% occurred in immunocompromised people with hepatitis and associated HAdV infections, compared with 10% in similarly infected immunocompetent patients with hepatitis. Detection of HAdV in serum by polymerase chain reaction (PCR) has been reported to predict severe disseminated infection in immunocompromised patients. Nephritis and kidney failure caused by HAdV infections have been reported in bone marrow transplant recipients. , A study of 532 hematopoietic stem cell transplant recipients between 1986 and 1997 found a 12% incidence of HAdV infections, with children being more likely than adults to have a positive culture (23% vs 9%).
HAdVs have been associated with a number of chronic disease conditions, including chronic airway obstruction, pulmonary dysplasia, myocarditis, and cardiomyopathy. Although the results of studies are mixed, an intriguing series of human and animal studies associate a number of HAdV types with obesity.
AdVs are nonenveloped, double-stranded DNA viruses belonging to the genus Mastadenovirus , family Adenoviridae . HAdVs were originally classified by species (A–G) through hemagglutination properties and by serotype (1–51) with horse or rabbit antisera ( Table 11.2 ). , , Different strains within serotypes can be further distinguished by whole-genome restriction-enzyme digest patterns. However, as serum typing reagents have become unavailable and sequencing costs have decreased, full genome sequencing has become the method of choice for classifying HAdV types. This has been used to describe as many as 111 unique HAdV types ( http://hadvwg.gmu.edu/ ).
Adenovirus Species | Types |
A | 12, 18, 31, 61 |
B | 3, 7, 11, 14, 16, 21, 34, 35, 50, 55, 66, 68, 76 -79, 106 |
C | 1, 2, 5, 6, 57, 89, 104, 108 |
D | 8–10, 13, 15, 17, 19, 20, 22–30, 32, 33, 36–39, 42–49, 51, 53, 54, 56, 58–60, 62–65, 67, 69–75, 80–88, 90–103 , 105, 107, 109–111 |
E | 4 |
F | 40, 41 |
G | 52 |
AdVs have an estimated diameter of approximately 920 Å. The viruses have an icosahedral capsid shell that is made up of 240 hexon bases, 12 penton bases, and 12 fibers that are associated with the penton bases ( Fig. 11.1 ). Four minor proteins (IIIa, VI, VIII, and IX) add to the complexity of the capsid.
AdV hexons are both type-specific and species-specific antigens, primarily inducing species-specific complement-fixing antibodies, whereas the fibers are especially active in hemagglutination. , The fibers also evoke type-specific antibodies, vary in length among human strains, and are sometimes absent in particular animal strains. The genome core of the virus is composed of five more proteins (V, VII, u, Iva2, and terminal protein) and a single molecule of linear, double-stranded DNA of 26 × 106 to 45 × 106 molecular weight. The G + C base compositions of the human virus genomes range from 47% to 60%.
AdVs are unusually stable to physical and chemical agents, as well as adverse pH, and can survive for long periods outside the host, making them available for transmission to others. They can be destroyed by heat at 56°C for 30 minutes, UV irradiation, 0.25% sodium dodecyl sulfate, chlorine at 0.5 µg/mL, and formalin, but are resistant to ether and chloroform.
AdVs replicate in the cell nucleus and tend to be very host-specific. However, there is mounting evidence that AdVs cross-species and occasionally humans and animals have exchanged AdVs.
Some species A HAdVs have been determined to be oncogenic in animals and to transform cell lines, but oncogenicity has not been observed in humans. Genetic recombination between HAdV types may occur. Sometimes, these recombinant strains or other emergent novel adenovirus strains lead to epidemics. A number of recent examples have been reported in the medical literature. ,
HAdV infections can be asymptomatic or cause disease depending on the route of inoculation, the type of virus, and the immune state of the host. Respiratory infection is presumed to result from inhalation of aerosolized virus, whereas ocular infection, gastroenteritis, and nosocomial infections may arise from fomites, water, or fecal–oral contact. Reactivation of latent HAdV is also believed to occur. Some 50% to 80% of surgically removed tonsils have detectable HAdV DNA by PCR, suggesting that these viruses may remain in a latent state for years. , Virus has been also isolated from lymphocytes, kidney, blood, cerebrospinal fluid, and most body organs. , , , In the lungs, extensive pathology has been found with microscopic necrosis of the tracheal and bronchial epithelium. Acidophilic intranuclear inclusions are seen in bronchial epithelial cells in addition to the basophilic masses of cells surrounded by clear halos, which may indicate aggregations of viral material. A mononuclear infiltrate, rosette formation, and focal necrosis of mucous glands are characteristically seen.
HAdVs can interact with cells in three ways. A lytic infection may take place during which the virus completes an entire replicative cycle resulting in cell death. Between 10 5 and 10 6 progeny viruses per cell are produced, of which only 1–5% are actually infectious. The second type of interaction is chronic or latent infection, in which small amounts of virus are produced, and the cell survives. Viral shedding from the gastrointestinal tract may occur for years. In fact, reactivation of such latent infection likely explains much HAdV disease in the severely compromised. Correspondingly, monitoring viral loads in the stool of transplant patients has predicted disseminated disease and been useful in guiding antiviral therapy. In addition to aerosolization, intestinal shedding of HAdV is an important factor to consider in the prevention of nosocomial spread in hospitals and chronic care homes. , , Persistent infection has been reported in epithelial cells from monkeys. Lymphoid cells are thought to be the reservoir for these persistent infections. , The third type of interaction is oncogenic transformation, whereby the viral DNA integrates into the host genome and replicates with the cellular host DNA, but only the early steps in the viral cycle occur and no infectious virions are produced.
The genes from adenoviruses are expressed in the cell nucleus in two phases: “early” (E), which precedes viral DNA replication, and “late.” Early genes encode proteins that function to thwart immunosurveillance, especially those from the E3 transcription unit. The late genes primarily encode viral structural proteins. The functions of the E1 proteins include the induction of DNA synthesis in quiescent cells, immortalization of primary cells in cooperation with activated ras or with the E1B proteins, transactivation of delayed early genes, induction or repression of several cellular genes, and induction of apoptosis. These proteins modulate the sensitivity of HAdV-infected cells to tumor necrosis factor (TNF), a key inflammatory cytokine with antiviral properties. None of the E3 genes are required for adenovirus replication in cultured cells, but several of the E3-coded proteins (10.4 K, 14.5 K, and 14.7 K) inhibit TNF cytolysis. , , Because a major function of TNF may be to prevent viral replication, the inhibition of TNF by these viral proteins may be a significant mechanism of pathogenesis.
Another significant E3-coded protein is Gp 19 K. This glycoprotein is located in the endoplasmic reticulum and forms a complex with class I antigens of the major histocompatibility complex (MHC), preventing cells from being killed by cytotoxic T lymphocytes. A cotton rat animal model was used by Ginsberg and colleagues and Ginsberg and Prince to study the pathogenesis of HAdV-2 and -5, which cause pneumonia similar to that seen in humans. , Two phases of infection were seen; the initial phase, characterized by the infiltration of monocytes and neutrophils, and a later phase associated with the infiltration of lymphocytes. The pathology seemed to reflect the response by host immune defenses to viral infection. The Gp 19 K markedly reduced the transport of the class I MHC to the surface of the infected cells and impeded the attack of cytotoxic T cells. , , It is now known that only the early genes are required to induce the complete pathogenesis of adenovirus infection in cotton rats. Although several cytokines, such as TNF-α, interleukin-1, and interleukin-6, were elaborated during the first 2–3 days of the infection in the cotton rat model, only TNF-α had a major role in pathogeneis. Steroids almost completely eliminated the pneumonic inflammatory response to infection.
Pathology caused by latent infection with HAdVs has been linked to chronic obstructive pulmonary disease (COPD). , Some have suggested that childhood viral diseases represent an independent risk factor for COPD. The adenoviral E1A proteins can stimulate the transcription of many heterologous viral and cellular genes. These proteins have the ability to interact with the DNA binding domains of several cellular transcription factors and activate a wide variety of genes. , The HAdV genome has been detected in the lungs of more patients with COPD than in control subjects. E1A proteins are expressed in epithelial cells of human lung tissue, and by increasing the expression of several genes important in controlling the inflammatory process, these may contribute to the pathogenesis of COPD. The events described may amplify the airway inflammation associated with cigarette smoking.
The isolation and cloning of a 46-kDa protein HAdV receptor, which mediates attachment and infection of species B viruses, may facilitate the development of new strategies to limit HAdV disease. The more common receptor is referred to as CAR. This protein has been identified as the receptor for the coxsackie B virus and HAdVs. Recently, another receptor, desmoglein 2, was identified for HAdV-3, -7, -11, and -14.
HAdV infections generally cannot be diagnosed on clinical grounds alone because the clinical signs and symptoms of these infections are variable and often resemble those caused by other pathogens. Qualified personnel and laboratory support are necessary to accurately diagnose HAdV infections. Considerations include specimen type and timing, collection and storage procedures, types of laboratory tests performed, and availability of appropriate diagnostic assays.
The optimal specimen for diagnosis of HAdV infection depends on the clinical presentation and the suspected type. HAdVs can be detected in a variety of specimens, including respiratory secretions, conjunctival scrapings and swabs, stool, blood, cerebrospinal fluid, and biopsied tissue specimens. Specimens should be collected early in the illness and shipped promptly at 4°C or on dry ice if immediate testing is not possible. Swab and fresh tissue specimens must be transported in appropriate viral transport media, , , , whereas fluid samples like urine, stool, and cerebrospinal fluid should not be further diluted. For culture, nonsterile specimens should be treated with antibiotics prior to inoculation. Stool specimens are brought to 10% to 20% suspensions with buffered saline and clarified by low-speed centrifugation. Blood for culture or molecular testing should be collected with an anticoagulant to prevent clotting. Serum separated from clotted blood samples can be used for serological diagnosis (see below).
Through biological amplification, cell culture offers a sensitive method for HAdV detection by monitoring for cytopathic effect (CPE). Because AdVs are generally host-specific, isolation of HAdVs is most easily accomplished in human cells. Most HAdVs have been successfully isolated in cell culture. Several diploid and continuous cell lines, including A549, HeLa, HEp-2, KB, MRC-5 and commercial mixed cell lines with A549 cells, reportedly give good overall recovery and produce typical CPE. , However, the fastidious enteric HAdVs, HAdV-40 and -41, are exceptional in requiring Graham-293 Ad5-transformed secondary HEK (human embryo kidney) cells for optimal primary isolation.
CPE may develop slowly in monolayers of inoculated cells necessitating several subpassages before becoming visible. Infected cells become rounded, enlarged, and refractile and aggregate into irregular “grape-like” clusters. A 4-week incubation with blind passage is recommended. A rapid procedure for culture identification of HAdV is the shell vial technique. Here, cell monolayers are inoculated with the clinical specimen, centrifuged, and stained after 2–3 days incubation with commercial monoclonal antibodies. Cell culture is declining as a routine diagnostic method for detection and identification of HAdVs due to cost and delays, being replaced by antigen and molecular detection techniques in most laboratories (see below). However, culture is the only means available for obtaining sufficient virus for immunotyping, assessing virus susceptibility to antivirals, and identifying infectious virus in clinical and environmental specimens.
Electron and immunoelectron microscopy were once commonly used to detect and identify the fastidious HAdVs in stool specimens from young children, thereby establishing their association with acute gastroenteritis. , , These methods are still used to localize virus in cells from biopsy and autopsy specimens to confirm disease association and to study disease pathology.
Detection of HAdV antigenic proteins can be accomplished by reacting with virus-specific polyclonal or monoclonal antibodies labeled with various reporter systems. Examples include enzyme immunoassay, immunofluorescence assay, and latex agglutination. , , These assays can be used to detect HAdV proteins directly in clinical specimens or to identify virus isolates. Immunoassays are simple to perform, less costly, and provide results more quickly than culture or molecular tests, but are generally less sensitive. Point-of-care antigen immunoassays , for rapid HAdV detection and immunohistological staining for HAdV antigens in biopsy and autopsy specimens are still in common use. ,
Molecular methods have mostly replaced classical culture and antigen detection for routine diagnosis of HAdV infection. The PCR assay has become a particularly popular alternative, offering the potential for rapid and sensitive detection and being easily tailored for species- and type-specific identification as described below. PCR assays using HAdV group-specific primers individually or combined in assays for multiple human pathogens have proven comparable or better than cell culture or immunodiagnostic methods for HAdV detection in clinical samples. A number of commercial multiplex assays for respiratory pathogens that include HAdVs have been cleared by the U.S. Food and Drug Administration (FDA) for clinical diagnostic use. Use of quantitative real-time PCR assays have the added benefit of allowing monitoring of virus levels that can be used to predict patient prognosis, manage chemotherapy, and monitor efficacy of antiviral therapy.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here